Friday, July 25, 2014 10:16:36 AM
BY UMARU FOFANA
FREETOWN Fri Jul 25, 2014 9:23am EDT
(Reuters) -
Sierra Leone officials appealed for help on Friday to trace the first known resident in the capital with Ebola whose family forcibly removed her from a Freetown hospital after testing positive for the deadly disease.
Radio stations in Freetown, a city of around 1 million inhabitants, broadcast the appeal on Friday to locate a woman who tested positive for the disease that has killed 660 people across Guinea, Liberia and Sierra Leone since an outbreak was first identified in February.
"Saudatu Koroma of 25 Old Railway Line, Brima Lane, Wellington," the announcement said. "She is a positive case and her being out there is a risk to all. We need the public to help us locate her."
Koroma, 32, a resident of the densely populated Wellington neighborhood, had been admitted to an isolation ward while blood samples were tested for the virus, Health ministry spokesman Sidi Yahya Tunis. The results came back on Thursday.
"The family of the patient stormed the hospital and forcefully removed her and took her away," Tunis said. "We are searching for her."
Fighting one of the world's deadliest diseases is straining the region's weak health systems, while a lack of information and suspicion of medical staff has led many to shun treatment.
DOZENS UNACCOUNTED FOR
Earlier this year, a man in Freetown tested positive for Ebola although he is believed to have caught it elsewhere.
According to health ministry data and officials, dozens of people confirmed by laboratory tests to have Ebola are now unaccounted for in Sierra Leone, where the majority of cases have been recorded in the country's east.
While international medical organizations have deployed experts to the field in an attempt to contain the outbreak, the World Health Organisation (WHO) said poor health infrastructure and a lack of manpower were hindering their efforts.
"We're seeing many of these facilities simply don't have enough people to provide the constant level of care needed," WHO spokesman Paul Garwood told a news briefing in Geneva on Friday.
There is no cure or vaccine for Ebola, which causes diarrhea, vomiting and internal and external bleeding. It can kill up to 90 percent of those infected, although the mortality rate of the current outbreak is around 60 percent.
The West African outbreak is the first time that Ebola, which was first discovered in what is now Democratic Republic of Congo in 1976, has appeared in heavily populated urban areas and international travel hubs.
Cases have already been confirmed in Conakry and Monrovia, the capital cities of Guinea and Liberia.
On Thursday authorities in Nigeria announced that they were testing a Liberian man for Ebola after he collapsed upon arrival at an airport in Lagos, the country's commercial capital and a mega-city of 21 million people.
(Additional reporting by Stephanie Nebehay; Writing by Joe Bavier; Editing by Tom Heneghan)
___________________________________
http://www.reuters.com/article/2014/07/25/us-health-ebola-africa-idUSKBN0FU1DB20140725
TKMR
Recent ABUS News
- Arbutus to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:17:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:13:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:31:17 AM
- Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 07/18/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 03:16:15 PM
- Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels • GlobeNewswire Inc. • 06/06/2024 03:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 10:00:21 AM
- Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure • GlobeNewswire Inc. • 06/05/2024 06:30:00 AM
- Arbutus to Participate in Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:10:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 10:00:18 AM
- Arbutus to Present Imdusiran Data at EASL Congress 2024 • GlobeNewswire Inc. • 05/22/2024 06:00:00 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 01:03:23 PM
- Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value • Business Wire • 05/17/2024 01:00:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/09/2024 12:00:20 PM
- Arbutus to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 11:30:00 AM
- Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024 • GlobeNewswire Inc. • 05/02/2024 11:25:00 AM
- Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 04/18/2024 11:30:00 AM
- Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna • GlobeNewswire Inc. • 04/04/2024 12:30:49 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM